NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Stock Market Expected to Remain Weak Amid Global Cues

The Indian stock market is expected to remain weak on Monday, April 6, due to higher crude oil prices, a stronger dollar, and mixed global cues. The US-Iran war has entered its sixth week, keeping oil prices near $110 a barrel and raising concerns about its ramifications for the Indian economy. In the near term, the market is expected to remain volatile, with global cues as the main dominating factor.

According to Jigar S. Patel, Senior Manager of Equity Technical Research at Anand Rathi Share and Stock Brokers, the near term outlook for the Nifty 50 remains mixed, but is turning more constructive on a broader timeframe. Patel highlighted that after sliding toward the 22,200 zone, the index staged a sharp rebound to 22,700, indicating firm demand at lower levels. This pullback, combined with a bullish divergence on the daily RSI, signals fading bearish momentum. However, definitive confirmation is still awaited.

IndexSupport LevelResistance Level
Nifty 5022,000-21,70023,100-23,400
Bank Nifty50,000-49,00052,500

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Patel underscored that the index continues to trade below the falling trendline resistance near 23,100, with a stronger supply zone around 23,400. "Only a decisive breakout above these levels would confirm a durable bottom and pave the way for a move toward new highs. Until then, volatility and consolidation may persist as sentiment stabilises," said Patel.

For Bank Nifty, Patel believes a bullish RSI divergence further indicates waning downside momentum. However, here too, confirmation is pending, with the key breakout zone placed around 52,500. "A sustained move above this level would signal a firm bottom. On the downside, the 50,000-49,000 zone is likely to act as strong support in the near term," said Patel.

Jigar Patel recommends buying the following three stocks for the next one to two weeks:

Birlasoft

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

  • Previous close: ₹370.85
  • Accumulate in the ₹370-355 zone
  • Target price: ₹470
  • Stop loss: ₹315

Patel highlighted that since April 2025, Birlasoft has been forming a meaningful base, developing a clear triple bottom pattern on the weekly timeframe. This structure, combined with a three-point bullish RSI divergence, indicates strong buying interest and suggests that the zone between ₹325-335 is acting as a robust long-term support area.

Natco Pharma

  • Previous close: ₹1,027.55
  • Buy in the ₹1,030-1,000 zone
  • Target price: ₹1,125
  • Stop loss: ₹950

Patel highlighted that Natco Pharma has recently rebounded from its previous breakout zone, reinforcing the strength of its ongoing uptrend. The Williams Alligator indicator shows all three lines aligned and running parallel, signalling an established and sustainable trend. Momentum indicators further support the bullish outlook.

Gujarat Ambuja Exports (GAEL)

  • Previous close: ₹140.35
  • Buy in the ₹140-135 zone
  • Target price: ₹155
  • Stop loss: ₹126

Patel highlighted that in December 2025, GAEL delivered a decisive breakout above its 50-week EMA after an extended consolidation phase, signalling a clear shift toward bullish sentiment. Following the breakout, the stock has seen a healthy retracement and is currently trading above the Williams Alligator on the weekly timeframe, reinforcing the strength of the prevailing trend.

Investor Takeaway

Investors should consider buying Birlasoft and Natco Pharma for short-term gains.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.